Literature DB >> 3082385

[Inhibition of thrombocyte aggregation by antioxidants].

K O Muranov, S B Gashev, L D Smirnov, A A Shvedova, V B Ritov.   

Abstract

The effects of antioxidants (3-hydroxypyridines, 5-hydroxypyrimidines, hindered phenols) on platelet aggregation were studied. All the compounds under study possessed low anti-aggregation activity against indometacin-sensitive aggregation (activation with arachidonic acid, 50 M). Half-maximal inhibition of aggregation was achieved at a concentration similar to that of the compounds used (10(-3) M in cases of indomethacin-insensitive aggregation, platelet activation by thrombine 1.5 mu/ml and Ca2+-ionophore A23187 1.5 g/ml). 4-methyl-2.6-ditretbutyl phenol (BHT) in the concentration range of 10(-5)-4 X 10(-5) M inhibited and in the concentration range of 4 X 10(-5)-10(-4) M activated indomethacin-sensitive aggregation. The latter effect was not observed in the absence of Ca2+ ions in the incubation medium. It is concluded that the effects of the antioxidants studied on platelet aggregation were due to their non-specific action on platelet membranes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082385

Source DB:  PubMed          Journal:  Biull Eksp Biol Med        ISSN: 0365-9615


  1 in total

1.  Clinical and therapeutic use of probucol.

Authors:  A Berg; M W Baumstark; I Frey; M Halle; J Keul
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.